CN Patent

CN102105169B — 用于治疗帕金森病的药物组合物

Assigned to Pharma Two B Ltd · Expires 2014-09-10 · 12y expired

What this patent protects

提供了用于治疗帕金森病的药物组合物，包含可药用载体和固定剂量组合的两种活性剂，活性剂选自在帕金森病患者中具有神经保护或症状效果或者两者的化合物，其中两种化合物的摩尔比在1∶1至1∶100的范围内。组合物配制成用于立即释放、控制释放或者立即释放和控制释放两者。

USPTO Abstract

提供了用于治疗帕金森病的药物组合物，包含可药用载体和固定剂量组合的两种活性剂，活性剂选自在帕金森病患者中具有神经保护或症状效果或者两者的化合物，其中两种化合物的摩尔比在1∶1至1∶100的范围内。组合物配制成用于立即释放、控制释放或者立即释放和控制释放两者。

Drugs covered by this patent

Patent Metadata

Patent number
CN102105169B
Jurisdiction
CN
Classification
—
Expires
2014-09-10
Drug substance claim
No
Drug product claim
No
Assignee
Pharma Two B Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.